ATEC

ATEC

USD

Alphatec Holdings Inc. Common Stock

$10.805-0.125 (-1.144%)

Reaalajas hind

Healthcare
Meditsiiniseadmed
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$10.930

Kõrge

$11.005

Madal

$10.715

Maht

0.78M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.6B

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

1.77M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $4.88Praegune $10.805Kõrge $13.14

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 3. juuli 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

ATEC: Alphatec Holdings Inc. Common Stock – Unpacking Recent Trends and Future Prospects

Stock Symbol: ATEC Generate Date: 2025-07-03 13:46:42

Alright, let's break down what's been happening with Alphatec Holdings and what the numbers might be telling us. This company, Alphatec, operates in the medical devices space, specifically focusing on spinal disorder treatments. They make everything from implants to imaging systems, aiming to improve spinal surgeries.

Recent News Buzz: A Positive Chorus

The vibe from recent news is definitely on the positive side. We've seen a few analyst updates, and they're all singing a similar tune:

  • Piper Sandler reiterated an "Overweight" rating and even bumped their price target up to $15 from $13. That's a vote of confidence right there.
  • Needham stuck with a "Buy" rating, keeping their price target at $16.
  • HC Wainwright & Co. also maintained a "Buy" rating, holding their price target at a more ambitious $20.

What does this mean? Essentially, these financial experts are looking at Alphatec and seeing good things ahead. They believe the stock has room to grow, and they're putting their targets where their mouths are. It's a strong signal of positive sentiment from the professional investment community.

Price Check: A Rollercoaster Ride, Now Settling

Looking at the last 30 days, ATEC's stock has had its ups and downs. It started around the $10 mark in early April, then saw a nice climb, hitting a peak around $13.14 in mid-May. After that, it pulled back a bit, and lately, it's been hovering around the $10.80 to $11.30 range. The current price is $10.84.

Comparing this to the AI's predictions, it's interesting. The AI model from AIPredictStock.com suggests:

  • Today's Prediction: 0.00% change (basically flat)
  • Next Day's Prediction: +0.62%
  • The Day after next day's Prediction: +1.05%

So, while the stock has seen some volatility, the AI is forecasting a slight upward drift in the very near term. This aligns with the overall positive analyst sentiment, even if the recent price action has been a bit choppy. The stock is currently sitting near a support level of $10.89, which could be a key point to watch.

Outlook & Ideas: Leaning Bullish, But Watch Your Step

Putting it all together, the current situation for ATEC seems to lean towards a potential buying opportunity, or at least a moment for accumulation. The strong analyst backing, coupled with the AI's short-term upward prediction, paints a generally optimistic picture.

  • Why it looks interesting: Analysts are bullish, and the stock has pulled back from its recent highs, potentially offering a better entry point. The AI also sees a slight upward trend coming. The company's P/E ratio at -16.8x is also better than the industry average of -25.2x, suggesting it might be undervalued compared to its peers. Plus, trading volume is way up, indicating strong buying interest.
  • Potential Entry Consideration: If you're thinking about getting in, a price around the current level, perhaps between $10.87 and $10.93, might be worth considering. This range is close to a recent support level, which could act as a floor.
  • Potential Exit/Stop-Loss Consideration: For managing risk, a stop-loss order below $9.87 could be a sensible move. This would help limit potential losses if the stock unexpectedly drops below recent significant lows. On the upside, a take-profit target around $11.19 could be considered, aligning with some of the immediate upward potential.

Company Context: Spine Focus is Key

Remember, Alphatec Holdings is all about spinal disorders. Their success hinges on their ability to innovate and sell their implants, instruments, and imaging systems. The fact that analysts are positive suggests they believe in the company's product pipeline and market position within this specialized healthcare sector. With 867 full-time employees, they're a significant player in their niche.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in the stock market involves risks, and past performance is not indicative of future results. Always conduct your own thorough research or consult with a qualified financial professional before making any investment decisions.

Seotud uudised

GlobeNewswire

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today

Vaata rohkem
iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 7. juuli 2025, 19:35

LangevNeutraalneTõusev

59.5% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
KasvVäärtus
Kauplemisjuhend

Sisenemispunkt

$11.01

Võta kasum

$11.20

Peata kahjum

$9.89

Põhitegurid

DMI näitab langustrendi (ADX:15.3, +DI:7.9, -DI:9.4), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($11.03) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 5.8x keskmisest (17,123), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0113 on signaalijoone 0.0265 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.